# Blood Pressure After Endovascular Stroke Therapy-II

Study · id `cardio:ct-nct04116112` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04116112](<https://clinicaltrials.gov/study/NCT04116112>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04116112

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT04116112. Randomized; single masking; primary purpose treatment. Start 2020-01-17 (actual); primary completion 2022-07-01 (actual). Results posted on 2023-10-12.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT04116112, source copy `cardio:ctgov-nct04116112-2023-10-12`, retrieved 2026-10-26)
- Started: 2020-01-17 (actual) (ClinicalTrials.gov record NCT04116112, source copy `cardio:ctgov-nct04116112-2023-10-12`, retrieved 2026-10-26)
- Primary completion: 2022-07-01 (actual) (ClinicalTrials.gov record NCT04116112, source copy `cardio:ctgov-nct04116112-2023-10-12`, retrieved 2026-10-26)
- Completion: 2022-12-15 (actual) (ClinicalTrials.gov record NCT04116112, source copy `cardio:ctgov-nct04116112-2023-10-12`, retrieved 2026-10-26)
- Results first posted: 2023-10-12 (ClinicalTrials.gov record NCT04116112, source copy `cardio:ctgov-nct04116112-2023-10-12`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04116112, source copy `cardio:ctgov-nct04116112-2023-10-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04116112-2023-10-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Blood Pressure After Endovascular Stroke Therapy-II
- Acronym: BEST-II
- Condition: Acute Stroke
- Condition: Endovascular Thrombectomy
- Intervention (Drug): Nicardipine
- Intervention (Drug): Labetalol
- Intervention (Drug): Hydralazine
- Lead sponsor: University of Cincinnati
- Lead sponsor class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH
- Collaborator: Vanderbilt University Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Cincinnati (`cardio:org-university-of-cincinnati`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)
- Registry lists this organization as a collaborator: Vanderbilt University Medical Center (`cardio:org-vanderbilt-university-medical-center`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial (`cardio:pubmed-37668620`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4c075f37de528f179575efa9a3718a3bcd68846652f6a911fd8b74c56da427a8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
